What can prevent a patient from moving into the progressive stage of shock?
Explanation & Rationale
Choice A rationale Drawing and monitoring laboratory values every 2 to 3 hours provides data on the patient's status but does not inherently stop the progression of shock. While values like lactic acid or arterial blood gases are informative, they are diagnostic rather than therapeutic. A normal lactic acid level is less than 2 mmol per liter. Monitoring simply tracks the decline if the underlying cause is not addressed through active medical or nursing interventions aimed at the pathology. Choice B rationale Correcting the initial cause of shock during the compensatory stage is the only way to prevent the body from entering the progressive stage. In the compensatory stage, the body's homeostatic mechanisms are still maintaining perfusion to vital organs. If the nurse and medical team can fix the problem, such as stopping a bleed or treating an infection, the spiral into organ failure can be avoided. This requires rapid identification and aggressive treatment of the primary insult. Choice C rationale Controlling pain and anxiety is an important part of holistic nursing care and can reduce the metabolic demand on the heart. However, it does not address the underlying physiological failure occurring in shock. While reducing stress might lower a high heart rate or blood pressure slightly, it will not restore systemic perfusion if the patient is suffering from sepsis or hemorrhage. Normal vital signs are a goal, but comfort measures alone cannot halt the progression of shock. Choice D rationale Completing a physical assessment every 15 minutes is a vital part of monitoring a critically ill patient for subtle changes in status. However, like lab monitoring, assessment is a tool for identification rather than a curative action. It allows the nurse to see if the patient is worsening, such as observing a drop in blood pressure below 90 mmHg systolic. While frequent assessment is necessary for safety, it does not stop the underlying disease process from advancing.